Catalyst Program

Shuvo Roy Lab

 

The Catalyst Program is UCSF’s translational accelerator focused on advancing UCSF discoveries with clinical impact and commercial potential. The Catalyst Program aims to foster academic and industry collaborations as well as enhance education in early translational research and entrepreneurship. 

Catalyst Awards

Fall 2018 Catalyst Awardees

The centerpiece of the Catalyst Program is the Catalyst Awards, our program that provide both industry advisor mentorship and seed funding to UCSF Principal Investigators with promising projects. The Catalyst Awards are focused on the development of therapeutics, diagnostics, medical devices, digital health, and biotools.

Summer Internship

The “Catalyst Awards Summer Internship Program” provides an opportunity to be part of an innovative project team to learn about early translational research and the process of translating academic discoveries into products for patient benefit. The primary focus for Catalyst Summer Interns is to draft Target Product Profiles (TPPs) for the 2018-2019 Catalyst Awardees. While creating the TPPs, interns will learn about intellectual property, competitive landscape, regulatory issues, clinical trial patient population selection, and clinical trial endpoints. 

learn more and APPLY

Case Studies

Case-based teaching has been extensively used in business schools and offers an advantageous model for bridging the gap between concept and practice. To complement existing classroom training in entrepreneurship on campus, and to offer more flexible and modular learning opportunities to academic translational scientists, Catalyst program has developed a series of case studies as a part of the online educational curriculum. We identify the best representative cases (many from UCSF) aligned to the core principles of startup business, and interview the founders of these startup companies, in particular the academic innovators. These cases highlight the challenges and real-world lessons learned from academic translational research to commercially viable products.

Learn More

Catalyst + Plus

The Catalyst Program expanded to Catalyst + Plus, a new addition that aims to provide additional support to past Catalyst projects with a successful progress yet still seeking business advice and/or supplemental funding.

Learn More


Resources

The Catalyst Program has compiled a list of disease databases, incidence & prevelance figures, core facilities information, as well as other useful links to guide researchers and students through the translation of therapeutic, diagnostic, medical device, digital health, and biotool discoveries to clinical impact .

Learn More

What We Do

  • Translating Science/Commercialization
  • Translational Funding
  • Technology Development

Our Team

  • Charles Hart, PhD

    Director

    Charles Hart is the director of the Catalyst program. From 2004 to 2017 he was at Threshold Pharmaceuticals and responsible for both in vitro and in vivo preclinical translational studies. He was also project leader for the global clinical development program for the hypoxia-targeted anticancer drug evofosfamide (TH-302), a partnership with Merck KGaA. Prior to joining Threshold, Charles was Senior Director of Biology at...

    Read more
  • Michael Lesh, MD

    Executive Director, Health Technology Innovation

    Michael D. Lesh, MD is a physician, scientist and entrepreneur. He earned undergraduate and graduate degrees in Computer Science and Bioengineering from the Massachusetts Institute of Technology (MIT) before entering medical school at the University of...

    Read more
  • Roopa Ramamoorthi, PhD

    Associate Director

    Roopa Ramamoorthi brings a diverse scientific background in drug development, bacteriology, biotechnology, and engineering. Prior to joining UCSF, Roopa was Associate Director Partnering and Scientific Affairs at BIO Ventures for Global Health, where her focus was putting together collaborations between academic, non profit and pharmaceutical organizations to accelerate the development of drugs, vaccines and diagnostics for Neglected...

    Read more
  • Jeni Janci, PhD

    Program Director

    Jeni began her life science career in the start-up biotech industry before earning her Ph.D. at University of California, Berkeley in Mike Levine’s laboratory. Her thesis was focused on gene regulatory networks of heart development in the primitive chordate, Ciona intestinalis. Directly after her graduate career, she re-entered the life science industry, where at Entelos she provided Quantitative Systems Pharmacology (QSP) Modeling and...

    Read more
  • Nathaniel Prorok

    Program Manager

    Nathaniel Prorok brings a diverse and wide ranging skill set and experience to the Catalyst Program team. After undergraduate studies in Physical Therapy and Athletic Training at Loyola...

    Read more

Funding